Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06026098 · ClinicalTrials.gov registry record · NA

Evaluation of Impact of AI Assistance on Workload Associated w Preparation of Rare Tumor Case Repts

A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

Not yet
Registry status
NA
Development phase
10
Enrollment target

NCT06026098: Clinical Trial NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT06026098 is a NA study that has not yet begun recruiting, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06026098, a NA study, has not yet begun recruiting, sponsored by UNC Lineberger Comprehensive Cancer Center.

NOT YET RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The goal of this study is to explore cognitive burden perceptions among physicians in relation to case report writing. Furthermore, this study evaluates the use of artificial intelligence (AI) assistance as a tool to reduce cognitive burden among providers preparing and submitting case reports. If an AI-tool is helpful in this setting, it may potentially help increase reporting of rare medical events and thereby improve the evidence base for care of these patient populations. This study will occur at a single time point which is expected to last approximately 2 hours. This session will include reviewing two rare tumor cases and then writing a clinical vignette with and without AI assistance.

Primary Outcome

Subjective Cognitive workload (CWL) will be measured while interviews using The National Aeronautics and Space Administration task load (NASA TLX) index is a tool for measuring and conducting a subjective mental workload (MWL) assessment. The NASA-TLX is a subjective measure of CWL and is used across many disciplines. The NASA-TLX considers six dimensions-Mental, Physical, and Temporal Demands, Frustration, Effort, and Performance. NASA-TLX scores ≥55 have been associated with reduced performan

Interventions

  • BEHAVIORAL Artificial Intelligence

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-10
Est. Completion 2026-12
Phase NA

What is known before NCT06026098 opens enrollment

NCT06026098 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Artificial Intelligence is the first listed.

NCT06026098 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06026098 about?

NCT06026098 is a clinical study titled "Evaluation of Impact of AI Assistance on Workload Associated w Preparation of Rare Tumor Case Repts". The goal of this study is to explore cognitive burden perceptions among physicians in relation to case report writing. Furthermore, this study evaluates the use of artificial intelligence (AI) assistance as a tool to reduce cognitive burden among providers preparing and submitting case reports. If a...

What is the current status of trial NCT06026098?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-10. Estimated completion is 2026-12.

What interventions are being tested in trial NCT06026098?

The interventions under investigation include: Artificial Intelligence (BEHAVIORAL).

Who is sponsoring clinical trial NCT06026098?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06026098's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT06026098, the US trial registry maintained by the National Library of Medicine. NCT06026098 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.